Super Religare Laboratories to raise $50m more in PE funding
Avigo Capital and Sabre Capital-backed diagnostics firm Super Religare Laboratories (SRL), which recently withdrew its IPO is raising $50 million(~Rs […]
Avigo Capital and Sabre Capital-backed diagnostics firm Super Religare Laboratories (SRL), which recently withdrew its IPO is raising $50 million(~Rs […]
Indegene Lifesystems Pvt Ltd., a scientific partner to global pharmaceutical and life sciences companies, today highlighted the benefits its pharmaceutical clients are reaping through comprehensive and multichannel patient support and adherence programs.
The cost of life saving vaccines is reduced from the world’s largest vaccine manufacturers from the US, UK and India.
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today on receiving recognition from The Rotary Foundation of Rotary International.
After the devastating earthquake, Lupin employees do come in full attendance for work as stated by Lupin president, Mr. Vinod.
The government is now planning to set up of over 8,000 drug retail outlets spread across the length and breadth of the country.
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
US approve the sale of low cost medicines by Glenmark Pharmaceuticals this financial year by winning the bids against Sun Pharma, Ranbaxy Laboratories and Dr Reddy.
Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level.
The RxNorm clinical drugs standard has been enhanced.
President and Managing Director, MSD Pharmaceuticals Limited K G Ananthakrishnan and leading paedetrician, Dr Manjira Mitra, announced the national launch of the unique health product in India.
Gujarat opens up a new plant set up by Jubilant Life Sciences (JLS) on Tuesday .
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.